SCHEMBL2188080

SCHEMBL2188080

CC(COS(C)(=O)=O)C1COC1

nearest known ligand 0.33

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ USP2 O75604 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ MMP9 P14780 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30643428 0.82 ALDH1A1 (0.37) ALDH1A1KDM4EUSP2LMNAMMP9
SCHEMBL2188626 0.78 KDM4E (0.30) ALDH1A1KDM4EUSP2LMNAMMP9
SCHEMBL28780402 0.75 LMNA (0.36) ALDH1A1KDM4ELMNATSHR
SCHEMBL12722103 0.73 — —
SCHEMBL18239640 0.73 — —
SCHEMBL27738664 0.71 ALDH1A1 (0.35) ALDH1A1LMNA
SCHEMBL28775691 0.71 — —
SCHEMBL18380837 0.69 — —
SCHEMBL18380830 0.69 — —
SCHEMBL15313205 0.69 ALDH1A1 (0.48) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101260094-B Tri (oxetane) compound, method for producing the same, and optical waveguide using the same NITTO DENKO CORP 2012-04-18 — — CN disclosed
EP-1992971-B1 Optical waveguide made of a polyfunctional oxetane compound having a dicyclopentadiene ring NITTO DENKO CORP (JP) 2011-07-13 — — EP disclosed
CN-101050207-B Trisoxetane compound, process for producing the same, and optical waveguide using the same NITTO DENKO CORP 2011-04-20 — — CN disclosed
EP-1958942-B1 Trisoxetane compound, process for producing the same and optical waveguide using the same NITTO DENKO CORP (JP) 2010-12-22 — — EP disclosed
US-7759503-B2 Trisoxetane compound, process for producing the same, and optical waveguide using the same NITTO DENKO CORPORATION (JP) 2010-07-20 — — US disclosed
US-7732562-B2 Trisoxetane compound, production process and optical waveguide therewith NITTO DENKO CORPORATION (JP) 2010-06-08 — — US disclosed
US-7587113-B2 Polydicyclopentadienes containing oxetane groups; moisture resistance; heat resistance NITTO DENKO CORPORATION (JP) 2009-09-08 — — US disclosed
US-20080285931-A1 OPTICAL WAVEGUIDE NITTO DENKO CORPORATION (JP) 2008-11-20 — — US disclosed
EP-1992971-A1 Optical waveguide made of a polyfunctional oxetane compound having a dicyclopentadiene ring NITTO DENKO CORPORATION (JP) 2008-11-19 — — EP disclosed
EP-1842849-B1 Trisoxetane compound, process for producing the same, and optical waveguide using the same NITTO DENKO CORP (JP) 2008-10-08 — — EP disclosed
US-20080221341-A1 Trisoxetane compound, process for producing the same, and opitcal waveguide using the same NITTO DENKO CORPORATION (JP) 2008-09-11 — — US disclosed
CN-101260094-A Tri-(oxetane) compounds, preparation method thereof and optical waveguide using the same NITTO DENKO CORP (JP) 2008-09-10 — — CN disclosed
EP-1958942-A1 Trisoxetane compound, process for producing the same and optical waveguide using the same NITTO DENKO CORPORATION (JP) 2008-08-20 — — EP disclosed
US-20070237963-A1 Trisoxetane compound, process for producing the same, and optical waveguide using the same NITTO DENKO CORPORATION (JP) 2007-10-11 — — US disclosed
EP-1842849-A1 Trisoxetane compound, process for producing the same, and optical waveguide using the same NITTO DENKO CORPORATION (JP) 2007-10-10 — — EP disclosed
CN-101050207-A Trisoxetane compound, process for producing the same, and optical waveguide using the same NITTO DENKO CORP (JP) 2007-10-10 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221341-A1 Trisoxetane compound, process for producing the same, and opitcal waveguide using the same OXER1, OPRD1, TRPC6 ALDH1A1 2067/4885KDM4E 842/4885USP2 3249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback